Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein.

This approach is applicable to any cell type that can be cultured in a laboratory (primary or cell line) as a method of investigating how protein challenge affects signalling pathways, providing additional understanding as to the role of protein aggregation in neurodegenerative disease initiation and progression.